Press esc to close search
Our education section provides in-depth guides and articles across a range of topics.
Our glossary is a great place to start if you’re new to the world of investing.
Trending Stocks
Nvidia Reaches All-Time High as Market Expectations Shift
Nvidia's stock hits an all-time high, with shifting market expectations for its future ranking as traders prepare for key earnings reports.
Trump's Criticism Sparks Market Speculation: Will He Insult Tucker Carlson by April 30?
Trump's recent comments escalate market speculation about potential insults, particularly targeting Tucker Carlson by April 30.
Nvidia's Market Cap Surges to $5 Trillion: What This Means for Investors
Nvidia achieves a $5 trillion market cap while holding a near-certain position as the largest company. What should investors watch for?
Exploring the Complexities of MVP Voting in the NBA
The MVP voting process involves team performance, player character, and strategic playoff adjustments, highlighting many complexities.
Tesla Shares Surge, Approaching Historic Highs and New Records
Tesla shares rose 4.1%, nearing its all-time high of $490, signaling strong market momentum and potential record-breaking performance.
Estée Lauder Stock (EL): Cautious Outlook Sparks Selloff
Estée Lauder's forecast misses expectations, raising concerns as it navigates e-commerce shifts and competitive pressures.
BitMine Immersion Technologies Stock (BMT: Crypto Hoarding Strategy)
BitMine Immersion Technologies sees a massive stock surge driven by crypto hoarding, now holding over 163,000 ETH worth over $500 million.
Zeta Global Stock (ZETA): Analyst Upgrade Boosts Outlook
Zeta Global is up 17% this month as AI-driven growth, fresh product launches, and bullish analyst calls ignite investor interest.
Yext Stock (YEXT): Strong Buy Consensus After Q1 FY 2026 Results
Yext's Q1 FY 2026 results show 14% revenue growth and strong buy consensus among analysts, indicating potential for continued growth.
Taysha Gene Therapies Stock (TSHA): Innovative Gene Therapy Focus
Taysha Gene Therapies (NASDAQ: TSHA) is gaining investor attention with TSHA-102, its lead Rett syndrome gene therapy. Learn why this biotech stock is a rising contender in the CNS space.
Serve Robotics Stock (SERV): Jumps 90%, What’s Next?
With SERV stock up 90%, investors are watching growth in robot deployment, revenue, and strategic partnerships. Should you buy now?
Capricor Stock (CAPR) Launch Hype Builds on Potential Breakthrough Therapy
Capricor Therapeutics (CAPR) stock climbs as FDA decision nears for its Duchenne therapy, with peak sales forecast at $3.3B by 2038.
2Seventy Bio (TSVT): Surge Following Acquisition Announcement
2Seventy Bio jumps 77% as Bristol Myers Squibb announces a $5-per-share buyout. Learn how this deal reshapes biotech investing and what it means for you.
Qualcomm Surpasses Earnings Expectations
Qualcomm's strong quarter showcases robust revenue growth, driven by automotive and handset sectors, alongside significant share buybacks and dividends for investors.
Top Ten Stocks Echo Dot-Com Bubble Risks
Spot the signs of a looming market correction. JPM strategists think top stocks mirror the dot-com era's risks.